These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 9743363)
1. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii. Khan IA; Matsuura T; Kasper LH J Immunol; 1998 Sep; 161(6):2994-3000. PubMed ID: 9743363 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808 [TBL] [Abstract][Full Text] [Related]
3. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. Yap GS; Scharton-Kersten T; Charest H; Sher A J Immunol; 1998 Feb; 160(3):1340-5. PubMed ID: 9570552 [TBL] [Abstract][Full Text] [Related]
4. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. Khan IA; Casciotti L J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393 [TBL] [Abstract][Full Text] [Related]
5. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963 [TBL] [Abstract][Full Text] [Related]
6. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice. Khan IA; Matsuura T; Fonseka S; Kasper LH J Immunol; 1996 Jan; 156(2):636-43. PubMed ID: 8543815 [TBL] [Abstract][Full Text] [Related]
7. Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection. Pfaff AW; Mousli M; Sénégas A; Marcellin L; Takikawa O; Klein JP; Candolfi E Int J Parasitol; 2008 Feb; 38(2):249-58. PubMed ID: 17822706 [TBL] [Abstract][Full Text] [Related]
8. Augmentation of the CD8+ T cell response by IFN-gamma in IL-12-deficient mice during Toxoplasma gondii infection. Ely KH; Kasper LH; Khan IA J Immunol; 1999 May; 162(9):5449-54. PubMed ID: 10228024 [TBL] [Abstract][Full Text] [Related]
9. Toxoplasma gondii: effect of sublethal irradiation on host resistance in mice. Johnson LL; Gibson GW; Sayles PC Exp Parasitol; 1995 Sep; 81(2):172-81. PubMed ID: 7556559 [TBL] [Abstract][Full Text] [Related]
10. Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain. Scharton-Kersten T; Caspar P; Sher A; Denkers EY Exp Parasitol; 1996 Nov; 84(2):102-14. PubMed ID: 8932760 [TBL] [Abstract][Full Text] [Related]
11. Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii. Johnson LL; Lanthier P; Hoffman J; Chen W Vaccine; 2004 Sep; 22(29-30):4054-61. PubMed ID: 15364456 [TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Deckert-Schlüter M; Rang A; Weiner D; Huang S; Wiestler OD; Hof H; Schlüter D Lab Invest; 1996 Dec; 75(6):827-41. PubMed ID: 8973478 [TBL] [Abstract][Full Text] [Related]
13. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. Kang H; Remington JS; Suzuki Y J Immunol; 2000 Mar; 164(5):2629-34. PubMed ID: 10679102 [TBL] [Abstract][Full Text] [Related]
14. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice. Khan IA; Kasper LH J Immunol; 1996 Sep; 157(5):2103-8. PubMed ID: 8757333 [TBL] [Abstract][Full Text] [Related]
15. Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA. Dimier-Poisson I; Aline F; Bout D; Mévélec MN Vaccine; 2006 Mar; 24(10):1705-9. PubMed ID: 16256251 [TBL] [Abstract][Full Text] [Related]
16. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. Suzuki Y; Remington JS J Immunol; 1988 Jun; 140(11):3943-6. PubMed ID: 3259601 [TBL] [Abstract][Full Text] [Related]
17. The CD28/B7 interaction is not required for resistance to Toxoplasma gondii in the brain but contributes to the development of immunopathology. Reichmann G; Villegas EN; Craig L; Peach R; Hunter CA J Immunol; 1999 Sep; 163(6):3354-62. PubMed ID: 10477605 [TBL] [Abstract][Full Text] [Related]
18. Toxoplasma gondii infection induces apoptosis in noninfected macrophages: role of nitric oxide and other soluble factors. Nishikawa Y; Kawase O; Vielemeyer O; Suzuki H; Joiner KA; Xuan X; Nagasawa H Parasite Immunol; 2007 Jul; 29(7):375-85. PubMed ID: 17576367 [TBL] [Abstract][Full Text] [Related]
19. Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii. Villegas EN; Elloso MM; Reichmann G; Peach R; Hunter CA J Immunol; 1999 Sep; 163(6):3344-53. PubMed ID: 10477604 [TBL] [Abstract][Full Text] [Related]
20. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii. Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]